article thumbnail

Why intelligent automation is the future for regulation

pharmaphorum

To improve data confidence regulatory executives should take a four-step approach to change how they: Collect Data: Life sciences organisations should utilise cloud-based solutions with global access that facilitates one repository with a single source of truth and eliminates the use of local file sharing and servers.

article thumbnail

Old Pharmacy vs New Pharmacy – How are you Operating?

pharmacy mentor

New Pharmacy: What Are The Differences Operations Overhaul: The Digital Revolution Old Pharmacy: Manual data entry, reliance on paper folders, sticky notes cluttering desktops, and limited computer use for Patient Medication Records (PMR).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How blockchain can revolutionise medical records and save lives

pharmaphorum

Many practitioners have expressed the feeling that EHRs cause far too much of their time ultimately being spent on data entry. Phones and similar devices now have the power and communication abilities to monitor an individual’s vitals and be an access point for both inputting and retrieving data.

article thumbnail

RFID: The future of smart labelling?

Pharmaceutical Technology

In August of 2022, Fresenius Kabi announced a three-year plan to add GS1 Data Matrix barcodes, also known as 2D barcodes, to its US pharmaceutical portfolio. The aim was to streamline workflows in healthcare facilities by reducing error-prone manual data entry for every customer.

Labelling 105
article thumbnail

Leveraging Technology | Case Study

PharmaState Academy

You foster an environment of open communication and collaboration, where every voice is heard and valued. Option 02 Increasing paperwork and manual data entry. You challenge the team to think creatively and strategically about how to navigate the upcoming months, encouraging them to share ideas and insights.

article thumbnail

Bringing the Benefits of eCOA BYOD Strategies to Clinical Studies

pharmaphorum

This precipitated a shift from a centralised trial experience to a decentralised one, resulting in participants communicating electronically. When data entry reminders arrive, the patient receives them immediately on a readily available mobile phone or smartwatch instead of on a device lying at home in a drawer.

article thumbnail

Considerations for safety data migration methods

European Pharmaceutical Review

For E2B and E2B hybrid migrations, it is important to consider the non-transferable data requirements for the database” If additional non-transferable data is required, a technical migration can be performed, which involves uploading ICSRs into the safety database as electronic E2B files with manual data entry for the additional data.